Inovio Pharmaceuticals
INO
#9228
Rank
HK$1.30 B
Marketcap
HK$11.84
Share price
24.28%
Change (1 day)
-29.17%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2023 (TTM): -HK$5.09

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$14.35. In 2022 the company made an earnings per share (EPS) of -HK$9.25 an increase over its 2021 EPS that were of -HK$11.37.

EPS history for Inovio Pharmaceuticals from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$5.09-44.97%
2022-HK$9.25-18.62%
2021-HK$11.3734.26%
2020-HK$8.47-10.74%
2019-HK$9.4915.24%
2018-HK$8.24-0.94%
2017-HK$8.314.95%
2016-HK$7.92129.55%
2015-HK$3.45-29.03%
2014-HK$4.86-55.71%
2013-HK$10.98141.38%
2012-HK$4.5520.83%
2011-HK$3.76-25%
2010-HK$5.02-56.76%
2009-HK$11.6123.33%
2008-HK$9.4111.11%
2007-HK$8.47-41.3%
2006-HK$14.43-67.14%
2005-HK$43.92115.38%
2004-HK$20.39-62.21%
2003-HK$53.96186.67%
2002-HK$18.82-0%
2001-HK$18.82-21.05%
2000-HK$23.84-58.7%
1999-HK$57.72

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.43-465.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.18-386.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-HK$24.31 69.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-154.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.57-257.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-HK$26.12 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA